Generate Biomedicines has filed for an IPO on the Nasdaq, seeking to raise upwards of $100 million for its AI-powered drug discovery operations. Incubated by Flagship Pioneering, Generate applies AI ...

Generate Biomedicines has completed its IPO, raising an impressive $400 million that makes it the largest listing for a biotech on the Nasdaq so far this year. Incubated by investment group Flagship ...

Discover Post For All's Random Giveaway Tool, the ultimate solution for effortlessly conducting social media contests. Boost engagement and reward your ...

Get the latest (GUID) stock news and headlines to help you in your trading and investing decisions.